
Interleukin 18 polymorphisms and its serum level in patients with multiple sclerosis
Author(s) -
Hamidreza Jahanbani-Ardakani,
Fereshteh Alsahebfosoul,
Masoud Etemadifar,
SeyedHossein Abtahi
Publication year - 2019
Publication title -
annals of indian academy of neurology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.427
H-Index - 31
eISSN - 1998-3549
pISSN - 0972-2327
DOI - 10.4103/aian.aian_515_18
Subject(s) - pathogenesis , multiple sclerosis , medicine , gastroenterology , genotype , interleukin 18 , case control study , interleukin , immunology , gene , genetics , cytokine , biology
Multiple sclerosis (MS) is a chronic demyelinating disorder of central nervous system. Although the definite pathogenesis of MS has not been understood, crucial role of environmental and genetic risk factors has been proposed.